FDA Approves New Dosing for Amprenavir and Ritonavir Combination
The FDA sent the following email on February 6, 2002:
|On February 5, 2002, FDA approved a new dosing regimen for Agenerase (amprenavir) and Norvir (ritonavir) used in combination. The "Dosage and Administration" section of the amprenavir package insert was revised to include the following statement:|
Concomitant Therapy: If Agenerase and ritonavir are used in combination, the recommended dosage regimens are: Agenerase 1,200 mg with ritonavir 200 mg once daily or Agenerase 600 mg with ritonavir 100 mg twice daily.
The following revisions were also made to the Agenerase package insert regarding the use of the Agenerase plus ritonavir.
The label hyperlinked below in PDF format:
ISSN # 1052-4207
Copyright 2002 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.
Back to the AIDS Treatment News March 8, 2002 contents page.